Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Hagemann

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2019
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive CancersUrs B Hagemann, Christine Ellingsen, Joachim Schuhmacher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
<sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in MiceLinda N Broer, Daan G Knapen, Frans V Suurs, et al.
Journal for Immunotherapy of Cancer|October 7, 2021
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapyPascale Lejeune, Véronique Cruciani, Axel Berg-Larsen, et al.
Physical Review Letters|June 21, 2001
Evidence for the wobbling mode in nucleiS W Odegård, G B Hagemann, D R Jensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2024
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate CancerChristoph A Schatz, Sabine Zitzmann-Kolbe, Ingrid Moen, et al.
Physical Review Letters|October 9, 2002
Evidence for second-phonon nuclear wobblingD R Jensen, G B Hagemann, I Hamamoto, et al.
Physical Review Letters|August 25, 2004
Compound and rotational damping in warm deformed rare-earth nucleiS Leoni, M Matsuo, A Bracco, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 9, 2019
Mesothelin-Targeted Thorium-227 Conjugate (MSLN-TTC): Preclinical Evaluation of a New Targeted Alpha Therapy for Mesothelin-Positive CancersUrs B Hagemann, Christine Ellingsen, Joachim Schuhmacher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 15, 2022
<sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in MiceLinda N Broer, Daan G Knapen, Frans V Suurs, et al.
Journal for Immunotherapy of Cancer|October 7, 2021
Immunostimulatory effects of targeted thorium-227 conjugates as single agent and in combination with anti-PD-L1 therapyPascale Lejeune, Véronique Cruciani, Axel Berg-Larsen, et al.
Physical Review Letters|June 21, 2001
Evidence for the wobbling mode in nucleiS W Odegård, G B Hagemann, D R Jensen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 9, 2024
Preclinical Efficacy of a PSMA-Targeted Actinium-225 Conjugate (225Ac-Macropa-Pelgifatamab): A Targeted Alpha Therapy for Prostate CancerChristoph A Schatz, Sabine Zitzmann-Kolbe, Ingrid Moen, et al.
Physical Review Letters|October 9, 2002
Evidence for second-phonon nuclear wobblingD R Jensen, G B Hagemann, I Hamamoto, et al.
Physical Review Letters|August 25, 2004
Compound and rotational damping in warm deformed rare-earth nucleiS Leoni, M Matsuo, A Bracco, et al.
Pageof 4